InflaRx N.V. (IFRX)
NASDAQ: IFRX · Real-Time Price · USD
1.170
-0.070 (-5.65%)
At close: Nov 13, 2026, 4:00 PM EST
1.140
-0.030 (-2.56%)
After-hours: Nov 13, 2026, 7:30 PM EST
InflaRx Employees
InflaRx had 65 employees as of December 31, 2025. The number of employees decreased by 9 or 12.16% compared to the previous year. That makes InflaRx the 33,890th largest employer in the world and 4,444th in the United States.
Employees
65
Change (1Y)
-9
Growth (1Y)
-12.16%
Revenue / Employee
n/a
Profits / Employee
-$512,299
Market Cap
172.42M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 65 | -9 | -12.16% |
| Dec 31, 2024 | 74 | 12 | 18.97% |
| Dec 31, 2023 | 62 | 18 | 40.41% |
| Dec 31, 2022 | 44 | -12 | -20.75% |
| Dec 31, 2021 | 56 | 9 | 18.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Sutro Biopharma | 129 |
| Invivyd | 122 |
| Zentalis Pharmaceuticals | 106 |
| BridgeBio Oncology Therapeutics | 88 |
| Alpha Cognition | 71 |
| Whitehawk Therapeutics | 37 |
| Eledon Pharmaceuticals | 33 |
| Sol-Gel Technologies | 28 |
IFRX News
- 5 days ago - InflaRx Transcript: 3rd Annual Guggenheim Healthcare Innovation Conference - Transcripts
- 9 days ago - InflaRx Announces Publication of Phase 1 Data Demonstrating Favorable Safety and Pharmacokinetic/Pharmacodynamic Profile of Izicopan - GlobeNewsWire
- 12 days ago - InflaRx sees up to $2B peak sales for izicopan in vasculitis, plans 2027 trials - TheFly
- 12 days ago - InflaRx Transcript: CMD 2026 - Transcripts
- 12 days ago - InflaRx Press release: FY 2026 - Filings
- 12 days ago - InflaRx Slides: FY 2026 - Filings
- 12 days ago - InflaRx Highlights Izicopan Development Path and Commercial Opportunity in ANCA-Associated Vasculitis at Capital Markets Day - GlobeNewsWire
- 19 days ago - InflaRx Announces November Investor Events - GlobeNewsWire